Medindia
Medindia LOGIN REGISTER
Advertisement

Bioponic Phytoceuticals CEO Issues Letter to Shareholders

Friday, November 30, 2007 General News
Advertisement
MAUI, Hawaii, Nov. 29 Bioponic Phytoceuticals,Inc. (Pink Sheets: BPYT) ("Bioponic"), an innovative provider of naturalproducts and patented technology serving the Complementary AlternativeMedicine (CAM) and nutraceutical markets, issued today a letter toshareholders from CEO and Chairman Steven M. Schorr to discuss the Company'smaterial developments during 2007.
Advertisement

Dear Shareholders:

I have great enthusiasm about Bioponic's achievements to-date, and theoutlook for the natural products and phytochemical production industry as awhole. Pharmaceuticals derived from plants account for over $10 Billion insales in the U.S. alone, and demand for plant-derived medicinals is on therise worldwide. By 2010, global sales of nutritional preparations and naturalmedicine will top nearly $200 Billion. Bioponic has over 94 proprietaryproducts in commercial production through our unique BioresonantPhytotherapeutic(TM) formulas and our proprietary Airponic Growth System thatenables the in-house production of the highest quality health and wellnessproducts.
Advertisement

I believe the following achievements during 2007 are leading up to anextraordinary year of growth for the Company and its shareholders in 2008:

From our local Hawaiian facility, we are capable of processing $150Million worth of wholesale products. With new global distribution channels andthe introduction of cutting-edge products such as Curemisinin, our scalableproduction capacity will enable us to meet current demand, fill orders andpursue OEM/private label agreements with companies like Malie Inc. who areutilizing our formulation and manufacturing expertise to bring their naturalcosmetic products to market.

I encourage you to learn more about our unique technologies, product linesand active ingredients by visiting our website and online store athttp://www.bioponic.com. I hope you'll find this additional information usefulin understanding Bioponic and the immense potential it represents for you as ashareholder. As always, I thank you for your time, interest and continuedsupport in Bioponic.

About Bioponic Phytoceuticals

Bioponic Phytoceuticals is engaged in the development, production anddistribution of Bioresonant Phytotherapeutic(TM) products. The Company hasdeveloped several branded product lines, including the nasal spray: FlightSpray(R) (http://www.flightspray.com); Curecumin(TM) (a treatment forAlzheimer's Disease); O-Spray(TM) (scented nasal sprays); Throat Note(TM)(formulated for professional speakers and singers, great for everyone!) andthe effective natural skincare product Hawaiian Healing Mist(TM). Bioponic isfocused on the production of natural products that are used to promote healthand well being.

All statements other than statements of historical fact included in thispress release are "forward-looking statements" within the meaning of federalsecurities laws. Such forward-looking statements are subject to a number ofrisks and uncertainties, some of which are beyond the Company's control.

CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711,

[email protected] or Geoffrey Eiten, Investor Relations, OTC Financial

Network, 781-444-6100x613, [email protected], www.otcfn.com/bpyt.-- This month, we launched Curemisinin(TM), an all-natural artemisinin-based treatment for malaria. Alternative anti-malaria medicines are in dire need in places like Africa, where every 30 seconds a child dies of the disease. According to the World Health Organization (WHO), "The inappropriate use of anti-malarial drugs in the past century contributed to widespread resistance in the malaria parasite to drugs such as chloroquine, leading to rising rates of sickness and death. Over the past decade, a new group of antimalarials-- known as artemisinin-based combination therapies
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close